About This Page
This is a clinician-written, evidence-based summary aligned to the USMLE Step 2 CK Content Outline. It is intended for medical students preparing for USMLE Step 2 CK. Management reflects current ACC/AHA, USPSTF, and APA guidelines. Always cross-reference with UpToDate, institutional protocols, and clinical judgment.
The Bottom Line
- BMI 25-29.9 = overweight; BMI >=30 = obesity; BMI >=40 or >=35 with comorbidity often meets bariatric surgery thresholds
- USPSTF: offer or refer adults with BMI >=30 to intensive, multicomponent behavioral interventions
- Assess comorbidities: diabetes, hypertension, dyslipidemia, OSA, NAFLD/MASLD, osteoarthritis, depression, and medications causing weight gain
- Effective obesity care combines nutrition, activity, behavioral strategies, sleep, mental health, anti-obesity medication when indicated, and long-term follow-up
- Avoid stigmatizing counseling; use patient-centered language and address social determinants of diet, activity, sleep, and medication access
Overview
Obesity is a chronic, relapsing, multifactorial disease involving neurohormonal, genetic, behavioral, environmental, medication-related, and social drivers. USMLE Step 2 CK tests BMI classification, screening for complications, behavioral interventions, medication contraindications, and bariatric surgery eligibility. The USPSTF recommendation emphasizes intensive, multicomponent behavioral interventions for adults with BMI >=30 rather than brief advice alone. Modern management should treat obesity as a chronic disease requiring follow-up, escalation, and relapse prevention.
Epidemiology
Obesity affects a large proportion of US adults and is associated with type 2 diabetes, hypertension, dyslipidemia, coronary artery disease, stroke, obstructive sleep apnea, osteoarthritis, infertility, GERD, gallstones, NAFLD/MASLD, depression, and several cancers. Obesity prevalence and complications are shaped by food environment, poverty, trauma, sleep disruption, built environment, marketing, medications, and healthcare access. Weight bias itself contributes to avoidance of care and worse outcomes.
Clinical Features and Risk Factors
Symptoms
Weight gain, limited mobility, exertional dyspnea, fatigue, snoring, daytime sleepiness, joint pain, reflux, infertility, or low mood may be present
Rapid unexplained weight gain, proximal muscle weakness, purple striae, or easy bruising suggests secondary endocrine cause such as Cushing syndrome
Cold intolerance, constipation, bradycardia, and fatigue may suggest hypothyroidism, though it is rarely the sole cause of severe obesity
Binge eating, night eating, trauma history, depression, anxiety, or alcohol use can complicate management
Medication-associated weight gain: antipsychotics, antidepressants, insulin, sulfonylureas, glucocorticoids, valproate, gabapentin, and beta-blockers
Signs
BMI >=30 kg/m2 defines obesity; BMI >=40 defines class III obesity
Central adiposity and elevated waist circumference increase cardiometabolic risk beyond BMI alone
Acanthosis nigricans suggests insulin resistance
Hypertension, hepatomegaly, edema, or signs of sleep apnea indicate obesity-related complications
Papilledema and headaches in a young woman with obesity can suggest idiopathic intracranial hypertension
Assessment and Screening for Complications
First-line
BMI and waist circumferenceBMI = weight kg / height m2. Waist circumference helps assess central adiposity and cardiometabolic risk
Blood pressureScreen for hypertension using accurate technique and confirm when elevated
Metabolic labsHbA1c or fasting glucose, lipid panel, ALT/AST for fatty liver risk, and renal function if medication or comorbidity assessment requires it
Medication reviewIdentify weight-promoting drugs and consider alternatives when clinically appropriate
Second-line
Sleep apnea screeningUse STOP-BANG or sleep history; order sleep study for snoring, witnessed apneas, resistant hypertension, or daytime sleepiness
Secondary cause testingTSH if symptoms of hypothyroidism; Cushing workup only if discriminatory features such as proximal weakness, bruising, and wide purple striae
Eating disorder and mental health screeningAssess binge eating disorder, depression, anxiety, trauma, substance use, and suicidality when clinically indicated
Specialist
Bariatric surgery evaluationConsider for BMI >=40 or BMI >=35 with obesity-related comorbidity; newer specialty criteria may include lower BMI thresholds in selected metabolic disease
Dietitian/obesity medicine referralUseful for intensive behavioral treatment, pharmacotherapy selection, eating disorder complexity, or weight regain after surgery
Management
USPSTF Behavioral Weight Loss Interventions for Adults with Obesity; US obesity medicine standards1
Intensive multicomponent behavioral intervention
- Offer or refer adults with BMI >=30 to intensive behavioral intervention
- Components: nutrition plan, calorie reduction, physical activity, self-monitoring, problem-solving, relapse prevention, and regular follow-up
- Higher contact hours and longitudinal support produce better outcomes than one-time advice
- Use respectful language: ask permission to discuss weight and focus on health goals rather than blame
2
Lifestyle and behavioral targets
- Dietary pattern: calorie deficit with sustainable Mediterranean, DASH, high-protein, or culturally appropriate approach
- Physical activity: gradually progress toward >=150 min/week moderate activity; resistance training preserves lean mass
- Sleep: address sleep apnea, short sleep duration, shift work, and insomnia
- Behavioral tools: food/activity tracking, stimulus control, coping plans, social support, and structured follow-up
3
Anti-obesity pharmacotherapy
- Consider when BMI >=30 or BMI >=27 with weight-related comorbidity after lifestyle foundation
- Options include GLP-1 receptor agonists or dual incretin agents, orlistat, phentermine/topiramate, naltrexone/bupropion, and others depending on contraindications and access
- Avoid sympathomimetic agents in uncontrolled hypertension or significant cardiovascular disease
- Avoid naltrexone/bupropion in seizure disorder, chronic opioid therapy, or uncontrolled hypertension
- Pregnancy: anti-obesity medications are generally contraindicated; use preconception counseling
4
Bariatric/metabolic surgery
- Classic criteria: BMI >=40 or BMI >=35 with obesity-related comorbidity such as diabetes, OSA, hypertension, or NAFLD/MASLD
- Requires multidisciplinary evaluation, nutritional counseling, psychological assessment, and lifelong micronutrient monitoring
- Common procedures: sleeve gastrectomy and Roux-en-Y gastric bypass
- Monitor for deficiencies: iron, B12, folate, calcium, vitamin D, thiamine, and fat-soluble vitamins depending on procedure
Complications
- Cardiometabolic: Type 2 diabetes, hypertension, dyslipidemia, ASCVD, stroke, and heart failure
- Respiratory: OSA, obesity hypoventilation syndrome, asthma worsening, pulmonary hypertension
- Hepatobiliary/GI: NAFLD/MASLD, gallstones, GERD
- Musculoskeletal: Osteoarthritis, chronic low back pain, mobility limitation
- Reproductive/cancer: Infertility, pregnancy complications, endometrial, breast, colorectal, kidney, and other cancers
- Treatment complications: Weight regain, medication adverse effects, post-bariatric micronutrient deficiencies, dumping syndrome, marginal ulcers
USMLE Step 2 CK Exam Tips
- 1BMI >=30 = obesity; USPSTF answer is intensive multicomponent behavioral intervention, not just "advise diet and exercise"
- 2Screen for diabetes, hypertension, dyslipidemia, sleep apnea, and fatty liver disease in obesity
- 3Cushing testing is not routine for obesity; look for proximal weakness, easy bruising, and wide purple striae
- 4Bariatric surgery classic indication: BMI >=40 or >=35 with serious comorbidity
- 5Weight-loss drugs are generally contraindicated in pregnancy
- 6Bupropion/naltrexone is contraindicated with seizure disorder or chronic opioid therapy
- 7Obesity hypoventilation = obesity + daytime hypercapnia; do not confuse with simple OSA
- 8Use nonstigmatizing counseling and address social determinants — increasingly tested in ethics/prevention stems
practicetest your knowledge on obesity screening & managementApply what you've learnt with USMLE Step 2 CK-style questions from the iatroX Q-Bank — preventive medicine and beyond.
open q-bank